rxstat › Shortages › Dasatinib
Dasatinib shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Dasatinib products are in shortage in Canada (1 of 14 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Jan 6, 2022
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageREDDY-DASATINIB
140MG · TABLET · DR REDDY'S LABORATORIES LTD
DIN 02514796 · since Jan 6, 2022, no end estimate · Requirements related to complying with good manufacturing practices.
ResolvedTEVA-DASATINIB
80MG · TABLET · TEVA CANADA LIMITED
DIN 02478331 · ended Jun 3, 2026 · Disruption of the manufacture of the drug.
ResolvedTARO-DASATINIB
20MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02499282 · ended Mar 13, 2026 · Disruption of the manufacture of the drug.
ResolvedTARO-DASATINIB
50MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02499304 · ended Mar 13, 2026 · Disruption of the manufacture of the drug.
ResolvedTARO-DASATINIB
70MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02499312 · ended Mar 13, 2026 · Disruption of the manufacture of the drug.
ResolvedTARO-DASATINIB
80MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02499320 · ended Mar 13, 2026 · Disruption of the manufacture of the drug.
ResolvedTARO-DASATINIB
140MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02499347 · ended Mar 13, 2026 · Disruption of the manufacture of the drug.
ResolvedTARO-DASATINIB
100MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02499339 · ended Feb 27, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-DASATINIB
20MG · TABLET · APOTEX INC
DIN 02470705 · ended Nov 20, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-DASATINIB
50MG · TABLET · APOTEX INC
DIN 02470713 · ended Oct 9, 2025 · Disruption of the manufacture of the drug.
ResolvedTARO-DASATINIB
50MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02499304 · ended Jan 23, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-DASATINIB
100MG · TABLET · APOTEX INC
DIN 02470721 · ended Sep 19, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 31 reports. All reports are on file with Health Canada.
What's happening
Dasatinib is currently affected by an active shortage report filed with Health Canada by DR REDDY'S LABORATORIES LTD.
The reported cause is: requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Recent changes
Common questions
When will Dasatinib be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Dasatinib in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Related drugs
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.